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Abstract
Background: This prospective study investigated major characteristics 
of E.coli colonizing the intestine of out-and in-patient infants, especially 
their association with CTX-M-type extended spectrum β-Lactamases 
(ESBLs), integrons and fluoroquinolones-resistance. 
Methods: A total of 288 stool samples were collected from infants 
aged less than 1 year which were admitted at the Pediatric Depart-
ment, Jordan University Hospital, Amman. The E.coli isolates were 
investigated using antimicrobial susceptibility tests and PCR for detec-
tion of CTX-M genes and integrons. 
Results: A total of 170 (59%) infants were colonized with E.coli. These 
included 73 (42.9%) females and 97 (57.1%) males. A significant dif-
ference was observed between gender and age groups according to 
the presence or absence of E.coli (P= 0.001). Multidrug resistant (MDR) 
accounted for 52 (30.6%) of the isolates and all these were ESBL 
producers. The detection rate of CTX-M genes among MDR E.coli 
isolates was 49 (94.2%), CTX-M group 1 accounted for 41 (87.8%) of 
the isolates, and 30 (73.2%) were CTX-M-15 producers. Only Class I 
integron was detected in 20/52 (38.5%) of MDR E. coli isolates, and 
resistance to fluoroquinolones accounted for 45/52(86.5%) of these 
isolates . A total of 33/52 (63.5%) of MDR E.coli isolates were resistant 
to potential quinolone resistance genes (parC) and (gyrA) in associa-
tion with CTX-M group. 
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Introduction 
In recent years, there is increasing incidence of 
CTX-M type ESBLs producing Enterobacteriaceae in 
causing serious infections associated with commu-
nity and hospitalized patients (1,2,3). For empirical 
treatment of the E.coli serious infections in infants, 
beta-lactam drugs including carbapenems are wide-
ly used despite the fact that increasing rates of E.coli 
are becoming resistance to carbapenemase and 
causing outbreaks of nosocomial infections (2,3). 
It has been observed that bacterial strains with the 
ESBL phenotype are often multidrug resistant in 
association with plasmids which carry other genes 
responsible for resistance to aminoglycosides, fluo-
roquinolones and trimethoprim-sulfamethoxazole. 
In particular, CTX-M-15 is among the commonest 
CTX-M variants, discovered in many genera Entero-
bacteriaceae across the world, and it was the most 
reported variant in Europe (1,2). In addition, E.coli 
strains carrying the CTX-M-15 were more increas-
ingly detected in community acquired infections in 
both developed and developing countries (1,4). 
Therefore, the global spread of carbapenemase-
producing Enterobacteriaceae constitutes a signifi-
cant threat for treatment of patients (3,5). 
The objectives of this study were to detect the inci-
dence of CTX-M ESBL-producing E. coli in associa-
tion with fluoroquinolones-resistance and Class I in-
tegrons colonizing the intestine of Jordanian infants.
Patients and Materials 
Patients & Data collection
This prospective study included a total of 288 in-
fants aged less than 1 year old who were admit-
ted to the Pediatric Department, Jordan University 
Hospital in Amman, Jordan. Feces samples were 
collected from all infants over the period March-
July 2012. A biographical data about each infant 
was obtained and registered on special form. Data 
included age, gender, name, duration of hospitaliza-
tion, disease history, and taking of antibiotic at the 
time of sampling and before 2 week of sampling, 
type of feeding. Ethical approval was obtained from 
the Institutional Ethical Committee at Jordan Univer-
sity Hospital and the Deanship of Scientific Research 
at the University of Jordan.
Collection of feces samples 
A total of 288 infants were investigated, of these 
154 (53.5%) were male infants with a mean age of 
2.43 ± 3.13 months; and 134 (46.5%) were female 
Conclusion: This study demonstrates that formula-fed infants, vaginal 
delivery and old age of infants were higher and significantly associated 
with colonization of E .coli. High incidence of CTX-M ESBL-producing 
E. coli was found in association with fluoroquinolones-resistance and 
Class I integrons colonizing the intestine of Jordanian infants.
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infants with a mean age of 2.69 ± 3.45months. 
A sample from stool or rectum from each infant 
was taken using a sterile cotton swab and then 
placed and transported in Amies transport media 
(Advanced trading agency, Co., Jordan) to the mi-
crobiology research laboratory for culture . 
Culture and identification E.coli
All collected samples were cultured within 1-3 hours 
on MacConkey agar (Oxoid, England) and incubated 
for 24 hr in 37°C. Five colonies that morphologically 
resemble lactose-fermented E. coli growth were se-
lected and sub-cultured on MacConkey agar again 
to obtain pure E.coli isolates. Pure growth of all sub-
cultured E.coli isolates were confirmed by the follow-
ing biochemical standard tests; including citrate and 
urease utilization, lactose and glucose fermentation 
in tube Kligler iron agar and indole production, and 
later representative of isolates were confirmed as 
E.coli by commercial RemelRapID ONE test (Remel 
INC, USA). Only one single E.coli isolates was in-
cluded for each patients, and all E.coli isolates were 
stored in cryotubes containing brain-heart infusion 
agar (Oxoid, England) with 15% glycerol at -70 ºC. 
Antimicrobial Susceptibility Testing
Antimicrobial susceptibility testing was performed 
on Mueller-Hinton agar (Oxoid, England) according 
to the recommendation of the Clinical Laboratory 
and Standards Institute (CLSI, 2012).6 The results 
were interpreted according to the guidelines of 
CLSI. E. coli ATCC 25922 strain was included as a 
control. The antimicrobials disks (Mast group ltd, 
England) used in our study (µg/disk) were: augmen-
tin (amoxicillin/clavulanic acid 20/10), cefuroxime 
(30), cotrimoxazole (trimethoprim-sulfamethoxazole 
1.25/23.75), gentamicin (10), nalidxic acid (30), ni-
trofurantoin (300), ciprofloxacin (5),amikacin (30), 
cefoxitin (30), ceftazidime (30), ceftriaxone (30) 
,cefotaxime (30) and gentamicin (10). In addition, 
minimum inhibitory concentration (MICs) of E.coli 
isolates to cefotaxime, ceftriaxone, imipenem, gen-
tamicin and ciprofloxacin were determined using 
E-test susceptibility (Oxoid, England). 
DNA extraction
E.coli DNA was extracted using the �-spin� To-
tal DNA Extraction Kit (Intron, Korea) according to 
the manufacturer’s protocol for isolation of bacte-
rial DNA. Multiplex PCR (mPCR) was used for the 
detection of major CTX-m phylogenetic groups in 
E. coli isolates which were resistant to >3 antibiotic 
classes (52 isolates), including resistance to cefo-
taxime and ceftriaxone. Four pairs of primers were 
used to detect 5 major CTX-m phylogenetic groups 
(CTX-M-1, CTX-M-2, CTX-M-8 and 25/26, CTX-
M-9) as described by Mirzaee et al.(7) and CTX-
M-15 as reported by Leflon-�uibout e tal.8 Also, 
potential fluoroquinolones-resistance genes (parC) 
and (gyrA) were detected as reported by Leflon-
�uibout et al (8). 
PCR detection of integrons 
Detection of class 1, 2 ,3 integrons in 52 multire-
sistant E. coli isolates was performed using primer 
pairs (Invitrogen, USA) as described by Dillon et 
al.(9) . 
Results 
Table 1 shows that 170/288 (59%) of the infants 
carried E.coli in their intestine; of these 73 emales 
(42.9%) and 97 males (57.1%) .The association be-
tween E. coli colonization and other potential con-
tributing factors such as gender, taking antibiotic 
before two week of sampling, taking antibiotic at 
time of sampling and presence of maternal infection 
within 4 weeks before delivery, was not significant, 
but a significant difference was found in relation 
THE INTERNATIONAL ARABIC JOURNAL 
OF ANTIMICROBIAL AGENTS
2013
Vol. 3 No. 4:3
doi: 10.3823/740
This article is available from: www.iajaa.org4
to age (P=0.000), type of feeding (P= 0.004) and 
mode of delivery (p= 0.006) as proved by Pearson 
Chi- square test . The antimicrobial susceptibility pat-
terns of 52/170 (30.6%) E. coli isolates are shown in 
Table 2. All these 52 E.coli isolate were multidrug 
resistant to (> 3 drugs) and all were ESBL produc-
ers. The detection rate of CTX-M genes among 
MDR E.coli isolates was 49 (94.2%), CTX-M group 
1 accounted for 41 (87.8%) of these isolates and 
30 (73.2%) were CTX-M-15 producers. Only Class 
I integron was detected in 20/52 (38.5%) of MDR 
E. coli isolates, and resistance to fluoroquinolones 
accounted for 45/52(86.5%) of these MDR isolates. 
A total of 33/52 (63.5%) of MDR E.coli isolates were 
also positive for both gyrA and parC genes in as-
sociation with CTX-M group. 
Discussion 
This study demonstrates that E.coli strains colonized 
59% of the Jordanian infants aged less one year. 
The intestines of infants aged less than one month 
have the lowest rate of colonization (44.2%) with 
E.coli (Table 1),and other studies Sweden and Bra-
zil have showed also to some extent similar results 
Table 1.  Univariate analysis of potential contributing factors associated with 170 E .coli isolates from 
intestines of Jordanian infants.
Contributing Factor
Escherichia coli






(1day - 30 days) 61(44.2) 77(55.8)
0.001*
0.298 (0.182-0.487)






Breast milk 56(47.9) 61(52.1)
0.004*
0.363(0.186-0.708)Milk formula 43(71.7) 17(28.3)
mixed 71(64) 40(36)





Previous antibiotic treatment 






Presence of maternal infection 
within 4 weeks before delivery
Yes 25(61) 16(39)
0.784 0.910(0.462-1.790)No 145(58.7) 102(41.3)
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(19,11). The present study has shown that vaginal 
delivery of infants was associated with higher and 
significant rates of E.coli colonization (P= 0.006) 
compared with cesarean delivery (Table 1). The 
study of Penders et al.(12) in Netherlands, has re-
ported that infants acquired similar prevalence rates 
of E.coli colonization (85-91%) when infants were 
born through natural vaginal delivery at home, hos-
pital or through caesarean section at hospital. 
The present study has shown that there was no 
statistically significant relationship between E.coli 
colonization of infants who have been treated with 
antibiotics at the time of sampling (60%; P=0.918) 
or before two week of sampling (54%; P=0.426), 
respectively. While breastfed infants have less sig-
nificant rates of E.coli colonization (P=0.004) than 
other feeding types. Previous studies have also re-
ported that formula-fed infants were more often 
associated with colonization of E .coli, C difficile, 
Bacteroides, and lactobacilli when compared with 
breastfed infants (12,13). 
This study shows the occurrence of high rate of 
MDR E. coli isolates (30.6%), and about 40% of 
these were associated with Class 1 integrons (Table 
2). In addition, the majority of these E. coli isolates 
(94.2%) were producers of CTX-M , and CTX-M-15 
type accounted for 73.2% of the isolates (Table 
3). This result is comparable to the rates ( ≥ 30%) 
reported in East and Southeast Asia, Latin America, 
and Southern Europe, but less rates were found 
in Australia, Northern Europe, and North America. 
However, the highest ESBL rates of E. coli were re-
Table 2. Distribution of Class 1 integrons genes in 52 MDR E.coli isolates (> 3 drugs).
Antibiotics
No. (%) of 
total resistant 
isolates







Ceftriaxone 51(98) >32 >32 20/51 (39) 1.000
Cefotaxime 50(96) >256 128 18/50 (36) 0.143
Cefixime 49(94) - - 18/49(37) 0.551
Augmentin 49(94) - - 19/49(39) 1.000
Naldixic acid 42(81) - - 17/42(41) 1.000
Ceftazidime 41(79) - - 16/41 (39) 0.176
Cortimoxazole 39(75) - - 19/39(49) 0.009*
Nitrofuronation 28(54) - - 11/28(39) 1.000
Ciprofloxacin 19 (37) >32 0.25 7/19(37) 0.871
�entamicin 18(35) 64 1 7/18(39) 1.000
Imipenem 1 0.25 0.25 1/1 (100) 0.385
* Significant value
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ported in India (≥ 80%) and China (≥ 60%), and al-
most all their isolates were susceptible to imipenem 
(MIC 0.12 – 0.5 μg/ml) (14,15). 
Studies performed few years ago in Jordan, have 
reported less prevalence rates of MDR E.coli isolates 
(19-25%) from clinical cases, healthy persons and 
effluent water, including incidence of co-resistance 
to second and third generations of cephalosporins 
(16,17). This fact illustrate how rapidly MDR E.coli 
strains can emerge due to their carrying CTX-M-
type ESBLs genes. The association of co-resistance 
in our isolates to antimicrobials such as aminoglyco-
sides, tetracyclines, chloramphenicol, trimethoprim, 
and quinolones may be considered an important 
factor in the spread and maintenance of ESBL-pro-
ducing E.coli (18). However, the frequency of resis-
tance to non-beta lactam antibiotics in this study is 
lower than that was reported in most other Middle 
East countries (4). 
It has also been reported that CTX-M-15 is a major 
enzyme of the CTX-M -1 group and was associ-
ated with epidemic outbreak and plasmids, and 
it is playing a role in conferring carbapenem re-
sistance (19). CTX-M-15 could be associated with 
other ESBLs encoding genes and resistance to other 
antimicrobial agents such as fluo roquinolones, and 
ami noglycosides (1,20). Recent studies have also re-
ported that ESBL-producing E. coli is a major reser-
voir for blaCTX-M-15 gene, and it has rapidly spread 
in E.coli strains isolated from human, animal and 
environment worldwide (2,21). 
The present study demonstrated that 38.5% of 
MDR E.coli isolates carried Class I integrons and 
were positive for one or both potential fl uroquino-
lone resistance genes (gyrA and parC). In particular, 
co-trimoxazole resistance was statically significant 
(P=0.009) with the presence of Class I integrons. 
Previous studies from Jordan indicated also higher 
incidence rates of Class 1 integrons in E. coli isolated 
from water (48%) and stool of normal adult popu-
lation (74%) especially in association with transfer-
able plasmids (16,22). It has been shown that the 
integron system has the ability to capture various 
Table 3. Distribution of CTX-M genes among 52 MDR of E .coli isolates
ESBL phenotypes No. (%) E.coli isolates
CTX-M group I* 24(46.1%)
CTX-M group I and CTX-M group II 12(23.1%)
CTX-M group II and CTX-M group 9 5(9.6%)
CTX-M group 9 3(5.8%)
CTX-M group I and CTX-M group 9 3(5.8%)
CTX-M group I, CTX-M group II and CTX-M group 9 2(3.8%)
 Non-typed 3(5.8%)
Total 52(100%)
*A total of 41/52E.coli isolates (87.8%) were identified producing CTX-M group I alone or in association with other CTX-M groups, of 
these 30/41(73.2%) were CTX-M-15 producers.
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resistance genes and to create novel combinations 
of resistance genes which may contribute for the 
evolution of MDR �ram-negative bacteria (23-26). 
In conclusion, the high rate of E. coli strains in feces 
of infants carried CTX-M-type ESBLs and associ-
ated with Class I integrons and fluoroquinolone-
resistant should be considered alarming sign since 
they may cause serious infection which can’t be 
easily treatable.
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